BiomX Inc. (NYSEAMERICAN:PHGE) Sees Significant Increase in Short Interest

BiomX Inc. (NYSEAMERICAN:PHGE) was the recipient of a significant growth in short interest during the month of March. As of March 15th, there was short interest totalling 31,600 shares, a growth of 24.4% from the February 28th total of 25,400 shares. Currently, 0.3% of the shares of the stock are sold short. Based on an average trading volume of 87,400 shares, the short-interest ratio is currently 0.4 days.

BiomX Stock Performance

BiomX stock traded up $0.14 during trading on Wednesday, reaching $0.63. 1,413,807 shares of the company were exchanged, compared to its average volume of 114,169. The company has a market cap of $11.44 million, a price-to-earnings ratio of -0.20 and a beta of 1.27. BiomX has a 52-week low of $0.48 and a 52-week high of $4.99.

Analysts Set New Price Targets

Separately, HC Wainwright upped their price objective on shares of BiomX from $2.00 to $21.00 and gave the company a “buy” rating in a research note on Tuesday.

BiomX Company Profile

BiomX Inc, a clinical-stage microbiome company, develops products using natural and engineered phage technologies designed to target and kill specific harmful bacteria. It targets bacteria that affect the appearance of skin, as well as chronic diseases, such as inflammatory bowel diseases (IBD), primary sclerosing cholangitis (PSC), cystic fibrosis (CF), atopic dermatitis, and colorectal cancer (CRC).